Sentiss Pharma Private Limited

Sentiss Pharma Private Limited - healthcare in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U74899DL1994PTC056894 Incorporated 13 January 1994 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company healthcare
Revenue · FY 2026
₹688.42 Cr
▲ 25% YoY
Net profit · FY 2026
₹159.73 Cr
Net margin 23.2%
EBITDA · FY 2026
₹387.7 Cr
EBITDA margin 56.3%
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹5.88 Cr
Issued & subscribed
Open charges
₹504.85 Cr
Satisfied ₹795.76 Cr
Company age
32 yrs
Est. 1994
Employees · EPFO
684
Provident fund records

About Sentiss Pharma Private Limited

Data last updated:

Sentiss Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 13 January 1994 and has been in existence for over 32 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1994PTC056894. Its GSTIN is 07AAACP1612Q1ZC (Delhi). The company holds 16 GST registrations, of which 14 are active.

The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹5.88 Cr. It was formerly known as Promed Exports Private Limited. It is led by directors including Deepak Bahri (Managing Director) and Canakapalli Bhaktavatasala Rao.

Its last annual general meeting (AGM) was held on 10 September 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 212 Ashirwad Commercialcomplex D – I Green Park, New Delhi, Delhi, India – 110016.

As per the financials filed for FY 2026, the company reported a revenue of ₹688.42 Cr, a growth of 25% compared to the previous year. For the same year it recorded a net profit of ₹159.73 Cr (net margin 23.2%) and EBITDA of ₹387.7 Cr (EBITDA margin 56.3%). Revenue has grown at a compounded annual rate (CAGR) of 36% over three years and 36% over five years.

The company has about 684 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Sentiss Pharma. As per MCA filings, the company has open charges of ₹504.85 Cr and satisfied charges of ₹795.76 Cr on record. Court records list 39 cases involving the company, including 28 filed by the company and 11 filed against it; 13 cases are pending. The company has 7 deals on record (6 secondary share transfers, 1 funding round), with disclosed funding of ₹10 Lakh; the latest was in November 2018. Its 3 peer companies in the Pharma industry (Formulations), with the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations) are compared by revenue, 1 larger and 2 smaller; the largest is Encube Ethicals Private Limited with revenue of ₹1,369 Cr. The company has 16 MSME Form 1 returns on record between 2018 and 2024, listing 116 overdue payments to 42 micro and small suppliers.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sentisspharma.com.

Company details

CIN U74899DL1994PTC056894
Registration Number 056894
Incorporation Date 13 January 1994
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

Sentiss Pharma Private Limited's registered office is in New Delhi, Delhi. Its website is sentisspharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    212 Ashirwad Commercialcomplex D – I Green Park, New Delhi, Delhi, India – 110016
  • Industry
    Healthcare, Medical & Laboratory Equipment

To see the full contact details of Sentiss Pharma Private Limited, buy the company report.

Comprehensive company report
Sentiss Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Sentiss Pharma operates one associated brand: Sentiss Pharma. Each brand links to its own profile.

BrandDescriptionWebsite
Develops and manufactures ophthalmic, inhalational, ENT, and specialty drugs worldwide.sentisspharma.com

Business activity

The main business activity of Sentiss Pharma is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturing21Manufacture of basic pharmaceutical products and pharmaceutical preparations

To see the full business activity and turnover split of Sentiss Pharma Private Limited, buy the company report.

Financials of Sentiss Pharma Private Limited

FY 2026 filings available

Sentiss Pharma Private Limited reported revenue of ₹688.42 Cr (up 25% YoY) for FY 2026.

Revenue · FY 2026
₹688.42 Cr ▲ 25%
Net profit · FY 2026
₹159.73 Cr margin 23.2%
EBITDA · FY 2026
₹387.7 Cr margin 56.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 25%
3 years · compounded
▲ 36%
5 years · compounded
▲ 36%
EBITDA CAGR growth
1 year
▲ 81%
3 years · compounded
▲ 18%
5 years · compounded
▲ 33%

Revenue has grown at a compounded annual rate (CAGR) of 36% over five years, including 25% growth in the latest year. EBITDA rose 81% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹688.42 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹387.7 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹159.73 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin56.3%
Net Profit Margin23.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Sentiss Pharma Private Limited, buy the company report.

Board of directors of Sentiss Pharma Private Limited

Sentiss Pharma has 6 current directors and 15 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Canakapalli Bhaktavatasala RaoDirector29 Apr 20197 Years 6 MonthsCurrent
Deepak BahriManaging Director01 May 199531 Years 6 MonthsCurrent
Mahesh Kumar GargDirector09 Jun 201511 Years 5 MonthsCurrent
Geeta MathurDirector17 Jul 20179 Years 4 MonthsCurrent
Sameer AgarwalDirector10 Feb 20251 Years 9 MonthsCurrent
Deepak Kumar KhungarDirector21 Nov 20241 Years 11 MonthsCurrent

Peer comparison

Sentiss Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Encube Ethicals Private Limited₹1,369 Cr (FY 2025)25.0%Mumbai, Maharashtra, India
Innova Captab Limited₹1,255.72 Cr (FY 2025)15.0%Thane, Maharashtra, India
Corona Remedies Limited₹1,202.35 Cr (FY 2025)18.0%Ahmedabad, Gujarat, India
Sentiss Pharma Private Limitedthis company₹688.42 Cr (FY 2026)₹159.73 Cr23.2%25.0%684New Delhi, Delhi, India

To see the full peer comparison of Sentiss Pharma Private Limited, buy the company report.

Auditor

Sentiss Pharma Private Limited is audited by MSKA & Associates for the financial year 2026.

Auditor firmFinancial yearFirm registration number
MSKA & AssociatesFY 2026105047W

Shareholding

The shareholding of Sentiss Pharma Private Limited is on record for 5 financial years, the latest being FY 2026, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2026FY 2025FY 2024FY 2023FY 2022
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Sentiss Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
₹504.85 Cr
Satisfied charges
₹795.76 Cr
Breakdown by lending institutions
Yes Bank Limited₹315.97 Cr
Others₹158.88 Cr
Hdfc Bank Limited₹30.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
25 Nov 2025101191596Yes Bank Limited₹230.97 CrOpen
15 Mar 2025101076333Others₹20 CrOpen
26 Nov 2024101006068Others₹54.88 CrOpen
28 Feb 2024100886443Hdfc Bank Limited₹30 CrOpen
23 Sep 2023100796746Others₹50 CrOpen

To see the full charge records of Sentiss Pharma Private Limited, buy the company report.

Total charge records: 33 View all charges

Deals & funding

Sentiss Pharma Private Limited has 7 deals on record (6 secondary share transfers, 1 funding round), with disclosed funding of ₹10 Lakh; the latest was in November 2018.

Total deals
7
Secondary share transfers
6
Funding round
1
Disclosed funding
₹10 Lakh

Deals on record (5 of 7)

WhenDealAmountParties
Nov 2018Secondary share transferUndisclosedSeller: 2 individuals
Dec 2014Secondary share transferUndisclosedBuyer: 2 individuals
Seller: an individual
May 2014Secondary share transferUndisclosedBuyer: Rubicon Securities Private Limited , 2 individuals
Seller: an individual
Nov 2013Secondary share transferUndisclosedBuyer: 2 individuals
Seller: Sidvim Lifesciences Private Limited
Jan 2009Funding round₹10 LakhInvestors: Sidvim Lifesciences Private Limited , an individual

To see the full deal history of Sentiss Pharma Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Sentiss Pharma Private Limited was last rated by Crisil on 30 Jun 2020.

Rating agencyRated onRating
Crisil30 Jun 2020

To see the full credit ratings and regulatory alerts of Sentiss Pharma Private Limited, buy the company report.

MSME payment delays

Sentiss Pharma Private Limited has 16 MSME Form 1 returns on record between 2018 and 2024, listing 116 overdue payments to 42 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 42)

SupplierAmount dueDue sinceReported on
Devashish Food Packaging and Research Private Limited
Klenzaids Contamination Controls Private Limited
Harikrushna Machines Private Limited
Aargus Global Logistics Private Limited
Vyanktesh Fabricraft Private Limited

To see the full MSME payment records of Sentiss Pharma Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Sentiss Pharma Private Limited has a workforce of 684 employees on its EPFO records as of May 2026, across 2 active EPFO establishments.

Employee count
684
Active EPFO establishments
2
Employee growth
1%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-27684
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Sentiss Pharma Private Limited, buy the company report.

GST

Sentiss Pharma has 16 GST registrations: 14 active and 2 cancelled or inactive. The first 4 active GSTINs are listed below.

Total GSTINs
16
Active
14
Cancelled / inactive
2
GSTINStateStatusRegistered on
07AAACP1612Q1ZCDelhiActive01 Jul 2017
02AAACP1612Q1ZMHimachal PradeshActive01 Jul 2017
06AAACP1612Q1ZEHaryanaActive01 Jul 2017
08AAACP1612Q1ZARajasthanActive01 Jul 2017

To see the full GST registrations and return filing status of Sentiss Pharma Private Limited, buy the company report.

Recent activity

Sentiss Pharma Private Limited has 21 board changes on record since 1995: 6 appointments and 15 cessations. The latest: Deepak Kumar Khungar ceased to be Additional Director on 16 Mar 2025.

AGM
Sentiss Pharma Private Limited last Annual general meeting of members was held on 10 Sep 2026 as per latest MCA records.
Filing
Sentiss Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Delhi.
Charges
A charge with Yes Bank Limited amounted to Rs. 230.97 Cr with Charge ID 101191596 was registered on 25 Nov 2025.
Charges
A charge with Others of Rs. 54.88 Cr registered on 26 Nov 2024 with Charge ID 101006068 was modified on 25 Nov 2025.
Charges
A charge with Yes Bank Limited of Rs. 85.00 Cr registered on 03 May 2018 with Charge ID 100185020 was modified on 25 Nov 2025.
Charges
A charge registered on 25 Jul 2024 via Charge ID 100959360 with Canara Bank was fully satisfied on 29 Aug 2025.
Ceased
Deepak Kumar Khungar ceased to be Additional Director.
Ceased
Sameer Agarwal ceased to be Additional Director.
Charges
A charge with Others amounted to Rs. 20.00 Cr with Charge ID 101076333 was registered on 15 Mar 2025.
Appointed
Sameer Agarwal was appointed as Director.
Charges
A charge with Others of Rs. 34.00 Cr registered on 23 Jan 2020 with Charge ID 100322555 was modified on 26 Dec 2024.
Charges
A charge with Others amounted to Rs. 54.88 Cr with Charge ID 101006068 was registered on 26 Nov 2024.

90 earlier events are in the company report.

News

Santis Pharma’s Investment Round From Abenex
18 Oct 2024 · Globallegalchronicle

Frequently asked questions

Sentiss Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 13 January 1994 (32+ years old) and is registered under CIN U74899DL1994PTC056894.

Sentiss Pharma has 6 current directors:

The latest financial statements of Sentiss Pharma on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 10 September 2026. Year-wise statements from 2015 are in the company report.

The GSTIN of Sentiss Pharma is 07AAACP1612Q1ZC, registered in Delhi. The company has 16 GST registrations in all, of which 14 are active and 2 are cancelled or inactive. Other active GSTINs include 02AAACP1612Q1ZM (Himachal Pradesh), 06AAACP1612Q1ZE (Haryana), 08AAACP1612Q1ZA (Rajasthan).

The CIN (Corporate Identification Number) of Sentiss Pharma is U74899DL1994PTC056894. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Sentiss Pharma has 39 court cases on record: 28 filed by the company and 11 filed against it. 13 are pending. Most are in the district courts.

Sentiss Pharma was incorporated on 13 January 1994, making it 32+ years old. It is registered with the Registrar of Companies, Delhi.

Sentiss Pharma has 7 deals on record (6 secondary share transfers, 1 funding round), with disclosed funding of ₹10 Lakh; the latest was in November 2018.

The peers of Sentiss Pharma by revenue are Encube Ethicals Private Limited, Innova Captab Limited, Corona Remedies Limited, all in the Pharma industry (Formulations), with the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations).

Deepak Kumar Khungar ceased to be Additional Director on 16 Mar 2025. Sameer Agarwal ceased to be Additional Director on 16 Mar 2025. Sameer Agarwal was appointed as Director on 10 Feb 2025. Sentiss Pharma has 21 board changes on record in total.

Sentiss Pharma has 16 MSME Form 1 returns on record between 2018 and 2024, listing 116 overdue payments to 42 micro and small suppliers. The latest return was filed on 29 Apr 2024.

Sentiss Pharma can be reached through the website sentisspharma.com. Its registered office is in New Delhi, Delhi, India.